Mallory Hackett

The companies expect the deal to close in the second quarter of 2021, subject to customary closing conditions.   

The keynote presenter at HIMSS’ Accelerate Health event shares his game plan for how stakeholders can use big data to improve the quality, safety and effectiveness of drug therapies.   

The agency will allow some COVID-19 tests to be used at home for regular asymptomatic testing.

Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures.   

The company’s digital therapy CureSight presents a new treatment method for amblyopia, also known as lazy eye, that doesn’t require patching.   

The company gained Karuna’s team, customers, technology and insights through the deal.  

The company boasted strong revenues and membership growth but took a hit in its GAAP net income.

While these features are built to be used by all working families on the Cleo platform, it’s those families who do face discrimination who will benefit the most.   

The deal is expected to close in the second quarter of 2021. It will value the combined company at approximately $1.1 billion.   

Smart speakers such as the Amazon Echo or the Google Nest can be used to monitor heart rhythms without physical contact as effectively as an electrocardiogram, according to research from the University of Washington published in Communications Biology.